Close Menu

NEW YORK (GenomeWeb) – A study presented at last week's San Antonio Breast Cancer Symposium has confirmed that women of all races and ethnicities can safely be treated according to the most recent analysis from the TAILORx trial, which were published by the ECOG-ACRIN Cancer Research Group in the New England Journal of Medicine in June 2018 and presented at the American Society for Clinical Oncology annual meeting in Chicago.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.